PSNL
Personalis, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$13.34-13.32%
Price as of Jul 20, 2026
PSNL profitability
Personalis, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 13.7%
- EBITDA margin
- -132.6%
- EBIT margin
- -158.9%
- Net margin
- -148.1%
- Free cash flow margin
- -131.2%
Returns
- Return on equity
- -37.5%
- Return on assets
- -29.4%
- Return on invested capital
- -34.9%
- Asset turnover
- 0.20x
Cash efficiency
- Cash from operations
- -$79.5M
- Cash per share
- $2.23
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.